NEWARK, Del. — According to Future Market Insights (FMI), the global semiconductor-based ultrasound imaging market is valued at USD 627.7 million in 2026 and is projected to reach USD 1,527.4 million by 2036, expanding at a 9.3% CAGR during the 2026–2036 forecast period. Demand is being supported by healthcare providers seeking compact imaging platforms that integrate transducer control, signal processing, and other electronics into smaller devices. Semiconductor integration is enabling portable systems that can support imaging across hospitals, point-of-care departments, and ambulatory settings.
The market is also being shaped by the expansion of portable diagnostic workflows. FMI notes that clinical teams increasingly value systems capable of answering focused diagnostic questions near the patient, while hospitals assess image quality, operator training, secure data management, service requirements, and integration with established imaging workflows before broader deployment.
👉 Get Detailed Market Forecasts, Competitive Benchmarking, and Pricing Trends:
https://www.futuremarketinsights.com/reports/sample/rep-gb-34145
Global Segment Leaders
- CMOS-Based Ultrasound Systems — 37.1% share: CMOS-based systems lead the semiconductor type segment in 2026, supported by integration density, software-defined control, and the ability to provide broad frequency coverage within compact electronics.
- Cardiovascular Imaging — 38.0% share: Cardiovascular imaging represents the leading application segment, reflecting recurring diagnostic and monitoring requirements and the need for repeatable cardiac measurements across specialist and emergency settings.
- Hospitals — 36.4% share: Hospitals account for the largest end-user share because semiconductor-based ultrasound platforms can support radiology, cardiology, emergency, critical-care, and other departmental workflows within established imaging infrastructures.
- Handheld Ultrasound Systems — 41.2% share: Handheld systems lead the device type segment as their smaller footprint and mobility allow imaging at the bedside, in ambulatory centers, and in space-constrained clinical environments.
Country-Level Performance
- UK – 10.3% CAGR: Structured public procurement and diagnostic imaging demand are supporting adoption. MHRA guidance updated in July 2026 states that medical devices must be registered before placement on the Great Britain market.
- Germany – 9.1% CAGR: Established specialist imaging networks and regulated medical-device adoption support market development. Operator qualification and documented ultrasound quality processes remain relevant to adoption.
- Japan – 8.9% CAGR: Compact equipment and established device oversight support portable imaging workflows. PMDA revised its mobile ultrasound imaging device review guideline on March 31, 2025.
- South Korea – 8.3% CAGR: Advanced digital infrastructure, concentrated tertiary hospitals, and domestic imaging-equipment production support technology adoption.
- USA – 7.1% CAGR: Broad point-of-care use, device clearance activity, and established manufacturer service networks support adoption across hospital and outpatient networks.
FMI’s five-country forecast shows a 3.2-percentage-point difference between the highest disclosed CAGR in the UK and the lowest in the USA. The report attributes country-level differences to regulatory access, procurement structures, reimbursement conditions, provider economics, training requirements, and service coverage.
Regional Context
Europe contains two of the fastest-growing profiled markets. The UK is projected to expand at 10.3% CAGR, supported by structured health-system purchasing and diagnostic workload, while Germany is forecast at 9.1% CAGR amid established clinical networks and formal conformity and quality requirements.
East Asia presents another significant growth cluster. Japan is projected to grow at 8.9% CAGR, with compact equipment and established regulatory oversight supporting portable workflows. South Korea follows at 8.3%, supported by domestic manufacturing capabilities and advanced digital infrastructure within tertiary hospitals.
North America, represented by the USA in the disclosed country forecast, is projected to grow at 7.1% CAGR. The market benefits from broad point-of-care applications and established manufacturer service networks, while fragmented purchasing structures and credentialing requirements can affect adoption among smaller providers.
FMI’s full regional assessment covers North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa, with country-level forecasts specifically disclosed for the USA, UK, Germany, Japan, and South Korea.
👉 Access the Complete Report in PDF Format:
https://www.futuremarketinsights.com/reports/brochure/rep-gb-34145
Drivers, Restraints and Opportunities
Portable diagnostic access remains a central market driver. Semiconductor-based ultrasound platforms can bring imaging closer to patients and reduce dependence on dedicated examination rooms for focused examinations. FMI also identifies hospital and point-of-care imaging expansion as an important source of demand.
Operator dependence remains a restraint. Compact hardware does not eliminate the need for scanning expertise, particularly for difficult anatomy and advanced examinations. Germany’s ultrasound quality framework includes requirements related to physician qualifications and quality assurance, illustrating how training and governance can influence adoption.
Connected workflow software presents an opportunity as healthcare organizations seek to standardize documentation, credentialing, quality review, and image management across point-of-care ultrasound programs. Butterfly Network’s Compass AI platform, launched in November 2025, is positioned around enterprise ultrasound program management and integration with EHR and PACS environments.
Competitive Landscape
The competitive landscape includes Butterfly Network, Exo Imaging, Clarius Mobile Health, GE HealthCare, Philips, Siemens Healthineers, Canon Medical Systems, and Samsung Medison. The market combines semiconductor-focused handheld ultrasound providers with diversified imaging companies offering broader clinical portfolios.
Butterfly Network and Exo Imaging compete through proprietary CMUT and pMUT architectures designed to integrate imaging capabilities into compact handheld platforms. Clarius Mobile Health focuses on wireless probes and software-enabled workflows, while GE HealthCare and Philips offer handheld, point-of-care, and advanced ultrasound systems backed by established service organizations.
Siemens Healthineers and Canon Medical Systems emphasize application breadth across established diagnostic imaging portfolios. Samsung Medison combines ultrasound hardware with automated technologies across women’s health and general imaging applications.
Key Recent Developments
- March 2026: Butterfly Network received FDA clearance for an automated gestational-age tool integrated with its handheld ultrasound solution. The company described a blind-sweep workflow designed to support gestational-age assessment without requiring conventional fetal biometric measurements.
- August 2025: GE HealthCare introduced the Vivid Pioneer cardiovascular ultrasound system with AI-enabled measurements and workflow tools. The platform received FDA clearance and CE marking.
- July 2026: Philips introduced the Alturion ultrasound system for high-volume clinical environments, incorporating AI-powered workflow features. The company stated that the system had FDA clearance and CE marking at launch across the United States and Europe.
- February 2025: Canon Medical Systems announced the Aplio beyond ultrasound system for diverse clinical environments and demanding workloads, emphasizing image quality and workflow efficiency.
Analyst Perspective
“Commercial adoption will depend on demonstrating consistent diagnostic performance across routine clinical environments rather than controlled evaluation settings. Healthcare providers are assessing whether semiconductor-based imaging platforms expand access while preserving image quality, clinical confidence, and workflow efficiency. Companies that combine robust clinical validation with secure data management, dependable service, and long-term software support will be better positioned to strengthen adoption across healthcare systems.”
— Anurag Sharma, Principal Analyst, Future Market Insights
About Future Market Insights
Future Market Insights (FMI) is a leading provider of market research and consulting services, offering syndicated and customized research across industries including healthcare, medical devices, and technology.
Access Full Report: https://www.futuremarketinsights.com/reports/semiconductor-based-ultrasound-imaging-market
Related Reports:
- Outpatient Chemotherapy-Free Cancer Treatment Market – https://www.futuremarketinsights.com/reports/outpatient-chemotherapy-free-cancer-treatment-market
- Portable MRI Systems Market – https://www.futuremarketinsights.com/reports/portable-mri-systems-market
- Prospera Donor-Derived Cell-Free DNA Transplant Monitoring Market – https://www.futuremarketinsights.com/reports/prospera-donor-derived-cell-free-dna-transplant-monitoring-market
About Future Market Insights (FMI)
Future Market Insights (FMI) is a global market intelligence and consulting firm providing comprehensive market research, competitive intelligence, and strategic business insights across industries. The firm delivers detailed forecasts, technology analysis, and data-driven recommendations that support informed decision-making for manufacturers, investors, distributors, and policymakers worldwide.
For Press & Corporate Inquiries
Rahul Singh
AVP – Marketing and Growth Strategy
Future Market Insights, Inc.
+91 8600020075
For Sales – [email protected]
For Media – [email protected]
For Web – https://www.futuremarketinsights.com
